FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
    • Publication highlights
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Links
  • Events
    • Guest lectures
    • Retreats
    • Symposium
  • News
✕
Published by Austin on July 4, 2016
Categories

Augenklinik

  • DateJuly 4, 2016
  • Executive Board
  • Research Groups
  • Central Projects
  • Associated projects
  • Alumni

Curriculum Vitae

PD Dr. med. Franziska Bucher, FEBO

Department of Ophthalmology
University of Cologne
Kerpener Straße 62
50937 Cologne, GERMANY
Email: franziska.bucher@uk-koeln.de

Scientific career

2005-2011 Studies at University Medical Schools in Erlangen, Zurich and Rotterdam

2011-11/2016 Resident at Center of Ophthalmology, University of Cologne

2013 Dissertation at the University of Cologne („magna cum laude“)

2013 Scientist in EU FP7 STRONG project

2015-17 Clinician-Scientist (Gerok) at the Post-Doc level in Project 1 “Induction of transplant tolerance by antihem- and antilymphangiogenic therapies” in the DFG Research Unit FOR 2240 “Angiogenesis, Lymphangiogenesis and Cellular Immunity in Inflammatory Diseases of the Eye” at the Department of Ophthalmology, University of Cologne

2016 Short-term Scientific Project, University College London, Ruhrberg Lab

2016 Euopean and German Board Examinations in Ophthalmology

2017 Habilitation in the Dept. of Ophthalmology, University of Cologne. Habilitation thesis title: “Alterations of the corneal subbasal nerve plexus in ocular and systemic diseases”

2017- Clinician-Scientist in the Department of Ophthalmology, Ruhrberg Lab, University College London UK

Prizes and honors

2008-2009 DFG scholarship (SFB 643)

2010-2011 ERASMUS scholarship for international trainings with the German Academic Exchange Service (DAAD)

2014-2015GEROK programme, University of Cologne

2014-2016 Post-Doc Grant, University of Cologne

2014 Dry Eye Research Prize,German Ophthalmological Society, Berlin

2015 Dry Eye Research Prize, German Ophthalmological Society, Berlin

2016 EU COST-STSM-BM1302 Travel Grant

Selected Publications

Hos D, Bucher F, Regenfuss B, Dreisow M, Bock F, Heindl LM, Eming SA, Cursiefen C. Interleukin-10 indirectly regulates corneal lymphangiogenesis and resolution of inflammation via macrophages. Am J Pathol. 2016 Jan;186(1):159-71.

Bucher F, Schneider C, Fink G, Cursiefen C, Lehmann HC, Heindl LM. Small-Fiber Neuropathy is associated with Corneal Nerve and Dendritic Cell Alterations: An In Vivo Confocal Microscopy Study. Cornea. 2015 Sep;34(9):1114-9.

Bucher F, Hos D, Muller-Schwefe S, Steven P, Cursiefen C, Heindl LM. Spontaneous long-term course of persistent peripheral graft detachments after Descemet’s membrane endothelial keratoplasty. Br J Ophthalmol. Dec 19 2014.

Bucher F, Hos D, Matthaei M, Steven P, Cursiefen C, Heindl LM. Corneal nerve alterations after Descemet membrane endothelial keratoplasty: an in vivo confocal microscopy study. Cornea. 2014 Nov;33(11):1134-1139.

Bucher F, Adler W, Lehmann HC, et al. Corneal nerve alterations in different stages of Fuchs’ endothelial corneal dystrophy: an in vivo confocal microscopy study. Graefes Arch Clin Exp Ophthalmol. 2014 Jul;252(7):1119-26.

Lipp M,* Bucher F,* Parthasarathy A, et al. Blockade of the VEGF isoforms in inflammatory corneal hemangiogenesis and lymphangiogenesis. Graefes Arch Clin Exp Ophthalmol. 2014 Jan;252(6):943-9. (*co-first authorship)

Hos D, Heindl LM, Bucher F, Cursiefen C. Evidence of donor corneal endothelial cell migration from immune reactions occurring after descemet membrane endothelial keratoplasty. Cornea. Apr 2014;33(4):331-334.

Bucher F, Bi Y, Gehlsen U, Hos D, Cursiefen C, Bock F. Regression of mature lymphatic vessels in the cornea by photodynamic therapy. Br J Ophthalmol. 2014 Mar;98(3):391-395.

Bucher F, Parthasarathy A, Bergua A, et al. Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis. Acta Ophthalmol. 2014 Mar;92(2):143-8.

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Esther Engel
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
esther.engel@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck